Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Kusec

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Hematological Oncology|October 28, 2003
Primary non-Hodgkin lymphoma of the humerus following traumatic injury: case reportV Stemberga, R Dobi-Babić, A Bosnar, et al.
Leukemia|February 25, 2006
hTERT, the catalytic component of telomerase, is downregulated in the haematopoietic stem cells of patients with chronic myeloid leukaemiaL J Campbell, C Fidler, H Eagleton, et al.
American Journal of Hematology|December 12, 1997
Telomere length in myelodysplastic syndromesJ Boultwood, C Fidler, R Kusec, et al.
Annals of Hematology|February 1, 1994
Granulocytic sarcoma of the prostate as the first manifestation of a late relapse of acute myelogenous leukemiaF Thalhammer, H Gisslinger, A Chott, et al.
Cancer|June 1, 1997
High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B-cell chronic lymphocytic leukemia. Results of an international multicenter randomized trial. International Society for Chemo-Immunotherapy, ViennaB Jaksic, M Brugiatelli, I Krc, et al.
European Journal of Haematology|September 1, 1995
Treatment of chronic lymphocytic leukemia in early and stable phase of the disease: long-term results of a randomized trialM Brugiatelli, B Jaksic, A Planinc-Peraica, et al.
Leukemia|April 23, 2010
High-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progressionJ Boultwood, J Perry, R Zaman, et al.
Haematologica|August 28, 2001
Clinical tumor cell distribution pattern is a prognostically relevant parameter in patients with B-cell chronic lymphocytic leukemiaO Jaksic, R Vrhovac, R Kusec, et al.
American Journal of Hematology|May 20, 1999
Telomere length shortening is associated with disease evolution in chronic myelogenous leukemiaJ Boultwood, C Fidler, P Shepherd, et al.
British Journal of Haematology|November 1, 1996
Amplification of mitochondrial DNA in acute myeloid leukaemiaJ Boultwood, C Fidler, K I Mills, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Hematological Oncology|October 28, 2003
Primary non-Hodgkin lymphoma of the humerus following traumatic injury: case reportV Stemberga, R Dobi-Babić, A Bosnar, et al.
Leukemia|February 25, 2006
hTERT, the catalytic component of telomerase, is downregulated in the haematopoietic stem cells of patients with chronic myeloid leukaemiaL J Campbell, C Fidler, H Eagleton, et al.
American Journal of Hematology|December 12, 1997
Telomere length in myelodysplastic syndromesJ Boultwood, C Fidler, R Kusec, et al.
Annals of Hematology|February 1, 1994
Granulocytic sarcoma of the prostate as the first manifestation of a late relapse of acute myelogenous leukemiaF Thalhammer, H Gisslinger, A Chott, et al.
Cancer|June 1, 1997
High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B-cell chronic lymphocytic leukemia. Results of an international multicenter randomized trial. International Society for Chemo-Immunotherapy, ViennaB Jaksic, M Brugiatelli, I Krc, et al.
European Journal of Haematology|September 1, 1995
Treatment of chronic lymphocytic leukemia in early and stable phase of the disease: long-term results of a randomized trialM Brugiatelli, B Jaksic, A Planinc-Peraica, et al.
Leukemia|April 23, 2010
High-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progressionJ Boultwood, J Perry, R Zaman, et al.
Haematologica|August 28, 2001
Clinical tumor cell distribution pattern is a prognostically relevant parameter in patients with B-cell chronic lymphocytic leukemiaO Jaksic, R Vrhovac, R Kusec, et al.
American Journal of Hematology|May 20, 1999
Telomere length shortening is associated with disease evolution in chronic myelogenous leukemiaJ Boultwood, C Fidler, P Shepherd, et al.
British Journal of Haematology|November 1, 1996
Amplification of mitochondrial DNA in acute myeloid leukaemiaJ Boultwood, C Fidler, K I Mills, et al.
Pageof 3